Cargando…
Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors
SIMPLE SUMMARY: Phosphoproteomics is essential for basic understanding of cell biology. However, analysis of the phosphoproteome remains far from comprehensive. Therefore, we proposed a new method to enrich a subset of the phosphoproteome and expand the scope of analysis by using in vitro kinase rea...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817674/ https://www.ncbi.nlm.nih.gov/pubmed/36612075 http://dx.doi.org/10.3390/cancers15010078 |
_version_ | 1784864802680602624 |
---|---|
author | Ogata, Kosuke Takagi, Shunsuke Sugiyama, Naoyuki Ishihama, Yasushi |
author_facet | Ogata, Kosuke Takagi, Shunsuke Sugiyama, Naoyuki Ishihama, Yasushi |
author_sort | Ogata, Kosuke |
collection | PubMed |
description | SIMPLE SUMMARY: Phosphoproteomics is essential for basic understanding of cell biology. However, analysis of the phosphoproteome remains far from comprehensive. Therefore, we proposed a new method to enrich a subset of the phosphoproteome and expand the scope of analysis by using in vitro kinase reactions. We showed our novel workflow identified and quantified the phosphopeptides which have not been observed in the conventional workflow. We also demonstrated that this method is effective for profiling kinase inhibitors. We envision our workflow could easily be adapted to target different subsets of the phosphoproteome by utilizing different sets of kinases, and should be applicable to variety of samples. ABSTRACT: We present a motif-targeting phosphoproteome analysis workflow utilizing in vitro kinase reaction to enrich a subset of peptides with specific primary sequence motifs. Phosphopeptides are enriched and dephosphorylated with alkaline phosphatase, followed by in vitro kinase reaction to phosphorylate substrate peptides with specific primary-sequence motifs. These phosphopeptides are enriched again, TMT-labeled, dephosphorylated to enhance MS-detectability, and analyzed by LC/MS/MS. We applied this approach to inhibitor-treated cancer cells, and successfully profiled the inhibitory spectra of multiple kinase inhibitors. We anticipate this approach will be applicable to target specific subsets of the phosphoproteome using the wide variety of available recombinant protein kinases. |
format | Online Article Text |
id | pubmed-9817674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-98176742023-01-07 Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors Ogata, Kosuke Takagi, Shunsuke Sugiyama, Naoyuki Ishihama, Yasushi Cancers (Basel) Article SIMPLE SUMMARY: Phosphoproteomics is essential for basic understanding of cell biology. However, analysis of the phosphoproteome remains far from comprehensive. Therefore, we proposed a new method to enrich a subset of the phosphoproteome and expand the scope of analysis by using in vitro kinase reactions. We showed our novel workflow identified and quantified the phosphopeptides which have not been observed in the conventional workflow. We also demonstrated that this method is effective for profiling kinase inhibitors. We envision our workflow could easily be adapted to target different subsets of the phosphoproteome by utilizing different sets of kinases, and should be applicable to variety of samples. ABSTRACT: We present a motif-targeting phosphoproteome analysis workflow utilizing in vitro kinase reaction to enrich a subset of peptides with specific primary sequence motifs. Phosphopeptides are enriched and dephosphorylated with alkaline phosphatase, followed by in vitro kinase reaction to phosphorylate substrate peptides with specific primary-sequence motifs. These phosphopeptides are enriched again, TMT-labeled, dephosphorylated to enhance MS-detectability, and analyzed by LC/MS/MS. We applied this approach to inhibitor-treated cancer cells, and successfully profiled the inhibitory spectra of multiple kinase inhibitors. We anticipate this approach will be applicable to target specific subsets of the phosphoproteome using the wide variety of available recombinant protein kinases. MDPI 2022-12-23 /pmc/articles/PMC9817674/ /pubmed/36612075 http://dx.doi.org/10.3390/cancers15010078 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Ogata, Kosuke Takagi, Shunsuke Sugiyama, Naoyuki Ishihama, Yasushi Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors |
title | Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors |
title_full | Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors |
title_fullStr | Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors |
title_full_unstemmed | Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors |
title_short | Motif-Targeting Phosphoproteome Analysis of Cancer Cells for Profiling Kinase Inhibitors |
title_sort | motif-targeting phosphoproteome analysis of cancer cells for profiling kinase inhibitors |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9817674/ https://www.ncbi.nlm.nih.gov/pubmed/36612075 http://dx.doi.org/10.3390/cancers15010078 |
work_keys_str_mv | AT ogatakosuke motiftargetingphosphoproteomeanalysisofcancercellsforprofilingkinaseinhibitors AT takagishunsuke motiftargetingphosphoproteomeanalysisofcancercellsforprofilingkinaseinhibitors AT sugiyamanaoyuki motiftargetingphosphoproteomeanalysisofcancercellsforprofilingkinaseinhibitors AT ishihamayasushi motiftargetingphosphoproteomeanalysisofcancercellsforprofilingkinaseinhibitors |